Table S2 from A First-in-Human Study of the New Oral Selective Estrogen Receptor Degrader AZD9496 for ER+/HER2− Advanced Breast Cancer

Autor:	Seock-Ah Im, Hazel M. Weir, Gaia Schiavon, Shethah R. Morgan, Justin P.O. Lindemann, Teresa Klinowska, Matthias Hoch, Komal Jhaveri, Richard D. Baird, Anne C. Armstrong, Manish R. Patel, Erika P. Hamilton
Rok vydání:	2023
Popis:	PK parameters for M5 following a single dose (Day 1) and multiple doses (Day 15)
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ced7bf7f2902d4c8a44515006033e93 https://doi.org/10.1158/1078-0432.22464378 Zobrazit plný text záznamu